Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

335 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Do female age and body weight modify the effect of individualized FSH dosing in IVF/ICSI treatment? A secondary analysis of the OPTIMIST trial.
Leijdekkers JA, van Tilborg TC, Torrance HL, Oudshoorn SC, Brinkhuis EA, Koks CAM, Lambalk CB, de Bruin JP, Fleischer K, Mochtar MH, Kuchenbecker WKH, Laven JSE, Mol BWJ, Broekmans FJM, Eijkemans MJC; OPTIMIST study group. Leijdekkers JA, et al. Among authors: lambalk cb. Acta Obstet Gynecol Scand. 2019 Oct;98(10):1332-1340. doi: 10.1111/aogs.13664. Epub 2019 Jun 21. Acta Obstet Gynecol Scand. 2019. PMID: 31127607 Free article. Clinical Trial.
The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial.
van Tilborg TC, Eijkemans MJ, Laven JS, Koks CA, de Bruin JP, Scheffer GJ, van Golde RJ, Fleischer K, Hoek A, Nap AW, Kuchenbecker WK, Manger PA, Brinkhuis EA, van Heusden AM, Sluijmer AV, Verhoeff A, van Hooff MH, Friederich J, Smeenk JM, Kwee J, Verhoeve HR, Lambalk CB, Helmerhorst FM, van der Veen F, Mol BW, Torrance HL, Broekmans FJ. van Tilborg TC, et al. Among authors: lambalk cb. BMC Womens Health. 2012 Sep 18;12:29. doi: 10.1186/1472-6874-12-29. BMC Womens Health. 2012. PMID: 22989359 Free PMC article. Clinical Trial.
Early initiation of gonadotropin-releasing hormone antagonist treatment results in a more stable endocrine milieu during the mid- and late-follicular phases: a randomized controlled trial comparing gonadotropin-releasing hormone antagonist initiation on cycle day 2 or 6.
Hamdine O, Broekmans FJ, Eijkemans MJ, Lambalk CB, Fauser BC, Laven JS, Macklon NS; CETRO trial study group. Hamdine O, et al. Among authors: lambalk cb. Fertil Steril. 2013 Sep;100(3):867-74. doi: 10.1016/j.fertnstert.2013.05.031. Epub 2013 Jun 27. Fertil Steril. 2013. PMID: 23809501 Free article. Clinical Trial.
Elevated early follicular progesterone levels and in vitro fertilization outcomes: a prospective intervention study and meta-analysis.
Hamdine O, Macklon NS, Eijkemans MJ, Laven JS, Cohlen BJ, Verhoeff A, van Dop PA, Bernardus RE, Lambalk CB, Oosterhuis GJ, Holleboom CA, van den Dool-Maasland GC, Verburg HJ, van der Heijden PF, Blankhart A, Fauser BC, Broekmans FJ; CETRO trial study group. Hamdine O, et al. Among authors: lambalk cb. Fertil Steril. 2014 Aug;102(2):448-454.e1. doi: 10.1016/j.fertnstert.2014.05.002. Epub 2014 Jun 11. Fertil Steril. 2014. PMID: 24929258 Free article. Review.
Follicle-stimulating hormone receptor polymorphism affects the outcome of ovulation induction in normogonadotropic (World Health Organization class 2) anovulatory subfertility.
Valkenburg O, van Santbrink EJ, König TE, Themmen AP, Uitterlinden AG, Fauser BC, Lambalk CB, Laven JS. Valkenburg O, et al. Among authors: lambalk cb. Fertil Steril. 2015 Apr;103(4):1081-1088.e3. doi: 10.1016/j.fertnstert.2015.01.002. Epub 2015 Feb 24. Fertil Steril. 2015. PMID: 25721191 Free article.
335 results